Literature DB >> 332215

Relation between concentrations of digoxin in the myocardium and in the plasma.

A Malcolm, J Coltart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 332215      PMCID： PMC483350          DOI： 10.1136/hrt.39.9.935

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  24 in total

Review 1.  The significance of blood levels of drugs.

Authors:  D W Vere
Journal:  Sci Basis Med Annu Rev       Date:  1972

Review 2.  Digitalis intoxication--diagnosis, management and prevention.

Authors:  G A Ewy; F I Marcus; S J Fillmore; N P Matthews
Journal:  Cardiovasc Clin       Date:  1974

Review 3.  The use of serum concentrations of digitalis for quantitative therapeutic decisions.

Authors:  L B Sheiner
Journal:  Cardiovasc Clin       Date:  1974

4.  The inotropic effects of digoxin in hyperkalemia. Relation to (Na+,K+)-ATPase inhibition in the intact animal.

Authors:  R H Goldman; D J Coltart; J P Friedman; G T Nola; D K Berke; E Schweizer; D C Harrison
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

5.  Physiological distribution of digoxin in human heart.

Authors:  D J Coltart; H G Güllner; M Billingham; R H Goldman; E B Stinson; S M Kalman; D C Harrison
Journal:  Br Med J       Date:  1974-12-28

6.  Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation.

Authors:  T Akera; F S Larsen; T M Brody
Journal:  J Pharmacol Exp Ther       Date:  1970-05       Impact factor: 4.030

7.  Correlation between the inotropic action of ouabain and its effects on subcellular enzyme systems from canine myocardium.

Authors:  H R Besch; J C Allen; G Glick; A Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

8.  Drug therapy. Serum drug concentrations as therapeutic guides.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

9.  Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy.

Authors:  J Coltart; M Howard; D Chamberlain
Journal:  Br Med J       Date:  1972-05-06

10.  Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs.

Authors:  S A Glantz; R Kernoff; R H Goldman
Journal:  Circ Res       Date:  1976-09       Impact factor: 17.367
View more
  6 in total

1.  The drug treatment of atrial fibrillation.

Authors:  K S Channer
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  Tissues concentration and excretion of deslanatoside C-3H in newborn and growing rabbits.

Authors:  A Marzo; P Ghirardi; G Lorenzi; A Marini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

4.  Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution.

Authors:  F Keller; M Molzahn; R Ingerowski
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

5.  Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

Authors:  T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

6.  Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.

Authors:  T Jogestrand; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.